PITAVASTATIN CALCIUM | A205955 | SAWAI USA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Kowa Company, Ltd. et al v. Sawai USA, Inc. et al 3 patentsANDA 205955pitavastatin calcium | S.D.N.Y. | 2014-07-23 | Terminated 2017-01-26 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$1.27
per ea
Lowest NADAC/Unit
$1.15
per ea
Brand NDCs
0
Generic NDCs
3
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00832605090PITAVASTATIN 4 MG TABLET | $1.27 | EA | Generic | — | 2026-06-17 |
| 00832604890PITAVASTATIN 1 MG TABLET | $1.20 | EA | Generic | — | 2026-06-17 |
| 00832604990PITAVASTATIN 2 MG TABLET | $1.15 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.